	Melanoma germline genetics: immune, cancer driver, and Wnt signaling genes. medRxiv Jayasinghe GJMSR, Shi J, Thakur R, Hartman RI, Wang H, Hoang PH, Dochtermann D, Anyaso-Samuel S, Seviiri M, Nguyen Q, Pavithra P, Tran TV, Wang X, Xu M, Hua X, Pastorino L, Pellegrini S, Di Nardo L, Millan-Esteban D, Mastrangelo M, Yu C, Bui-Raborn LT, Dutta D, Pluta J, Yon J, Zhang T, Choi J, Patil S, Zhou X, Mukherjee B, Thomas LF, Brumpton BM, Hveem K, Løset M, Mulford AJ, Sanders AR, Lee CH, Myers T, Jessop L, Bravo-Narula J, O'Brien A, Williams J, Vartanian N, Kenny EE, Loos RJF, Schadendorf D, Zaremba A, Demenais F, Han J, Amos CI, Kanetsky PA, Cust AE, Hayward NK, Montgomery GW, Martin NG, Ward SV, Khosrotehrani K, Duffy DL, Sturm RA, Mann GJ, Soyer HP, Palmer JM, Bakshi A, Newton Bishop JA, Bishop DT, Vogt A, Hicks BD, Jones KM, Hutchinson A, Haley JS, Smelser DT, Carey DJ, Dong X, Sargen MR, Zhang H, Kim J, Rodolfo M, Stefanaki I, Carrera C, Di Prete M, Olsen CM, Pandeya N, Thompson JF, Spillane AJ, Shannon KF, Menzies AM, Lo S, Rentería ME, Pyarajan S, Fillmore NR, Hwang JC, Huhmann L, Cota C, Goryachev SD, Stratigos A, Hurlbert MS, Pellegrini C, Semenov YR, Nathanson KL, Do NV, Calista D, Gaziano JM, Peris K, Pereira AC, Fargnoli MC, Fritsche LG, Lacaze P, MelaNostrum Consortium, GenoMEL, Melanoma Meta-Analysis Consortium, Million Veteran Program, Goldstein AM, Stewart DR, Puig S, MacGregor S, Nagore E, Whiteman DC, Chanock SJ, Menin C, Long GV, Ghiorzo P, Iles MM, Wheless LE, Brown KM, Law MH, Landi MT. PMID: 42999374 [PubMed]
	Development and validation of machine learning-based models for identifying synchronous distant metastasis at initial diagnosis in cutaneous melanoma using the SEER database. Transl Cancer Res Wang H, Li J, Zhang F, Yang Y, Chen J, Huang G. PMID: 42997908 [PubMed]
	Resolving melanoma heterogeneity at single-cell resolution: implications for target discovery and therapy resistance. Br J Pharmacol Jin M, Song J, Xin Y, Tan Q, Qin Z, Wang Z, Zhang L. PMID: 42995141 [PubMed - as supplied by publisher]
	Intralesional and intratumoral therapies in melanoma: current evidence and future perspectives-a narrative review. Ann Transl Med Hernández-Santacana M, Guilarte-Cadavide C, Ayguasanosa-Àvila M, Balado-Simó P, Serra-García L, Aguilera-Peiró P, Albarrán-Fernández V, Balsa M, Ortiz-Brugués A, Podlipnik S, Arance A, Carrera C, Puig S, Malvehy J. PMID: 42991423 [PubMed]
	Neoadjuvant therapy in resectable cutaneous melanoma: a systematic review and meta-analysis of 35 trial arms. Melanoma Res Petrelli F, Ghidini A, Zambelli A, Merelli B. PMID: 42989947 [PubMed - as supplied by publisher]
	Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial. Nat Commun Ruffin AT, Mallow CL, Olson BM, Hammons J, Melendez B, Chelvanambi M, Gersz EM, Wittling MC, Diggs LP, Reilly C, Switchenko JM, Lazar AJ, Swisher SK, Kim J, Burns B, Harutyunyan A, Fisher TL, Delman KA, Yushak ML, Parker DC, Lawson D, Wargo JA, Zauderer M, Evans EE, Paulos CM, Lowe MC, Lesinski GB. PMID: 42982815 [PubMed - indexed for MEDLINE]
	Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for melanoma brain metastases. Neurosurg Rev Reyes JS, Bouras A, Lunsford LD, Niranjan A, Hadjipanayis CG. PMID: 42980889 [PubMed - indexed for MEDLINE]
	Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance. Front Immunol Riccardo F, Conti L, Defilippi P, Arina P, Audrito V, Calautti E. PMID: 42979158 [PubMed - indexed for MEDLINE]
	Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials. Nat Med Amaria RN, Chesney JA, Betof AS, In GK, Shoushtari AN, Johnson TT, Hamid O, Samhouri Y, Davies MA, Tawbi HA, Glitza Oliva IC, Aksoy BA, Kelly AM, Duan R, Prabhakar P, Ramsingh G, Jagasia M, Hari P. PMID: 42977756 [PubMed - as supplied by publisher]
	Acral melanoma: a unique subtype requiring unique solutions. Trends Cancer Possik PA, Robles-Espinoza CD, Adams DJ, Rebecca VW, Yeh I, Robertson GP, Couts KL, Smalley KSM, Judson-Torres RL, Aplin AE, Neumann NM, Semenov YR, In GK, Levy J, Hurlbert MS, Acral Melanoma Research Consortium, Bastian B, White R, Villanueva J. PMID: 42977670 [PubMed - as supplied by publisher]
	A Review of the Use of Ex-Vivo Confocal Microscopy in the Management of Non-Melanoma Skin Cancers. Dermatol Surg Alladeen A, Vijayvargiya N, Anumolu A, Mahadeo S, Minkis K. PMID: 42975558 [PubMed - as supplied by publisher]
	Exploring the potential role of PD-L2 in primary melanoma immunotherapy resistance: a hypothesis-driven dual-ligand framework. Front Immunol Song W, Tao Y, Ji X, Fu W, Cai X, Shan X. PMID: 42974102 [PubMed - indexed for MEDLINE]
	The gut microbiome in immunotherapy - lessons learned from melanoma and implications for gastrointestinal tumors. Best Pract Res Clin Gastroenterol Westphal JR, Macke L, Graf C, Schulz C. PMID: 42971667 [PubMed - indexed for MEDLINE]
	Pre-treatment machine learning prediction of local failure and time to local failure after Gamma Knife radiosurgery for radioresistant brain metastases. J Neurooncol Reyes JS, Shohayeb MAM, Bouras A, Lunsford LD, Hadjipanayis CG, Niranjan A. PMID: 42970176 [PubMed - indexed for MEDLINE]
	B cells and the therapeutic index of checkpoint blockade. J Clin Invest Li CY. PMID: 42969237 [PubMed - indexed for MEDLINE]
	Treatment patterns and characteristics of Chinese patients with advanced or resectable melanoma: a multicenter retrospective study. Future Oncol Jiang Y, Gu J, Chen Y, Zhang X, Qiu Y, Liu J, Lin J, Sheng X, Fan H, Li H, Jin X, Tang W, Guo J, Fang M, Si L. PMID: 42968552 [PubMed - as supplied by publisher]
	Microbiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma. Cancer Immunol Immunother Haferkamp S, Schilling B, Baumgart L, Gesierich A, Glutsch V, Drexler K, Wein L, Morak M, Erdmann M, Berking C, Piccinno G, Derosa L, Zitvogel L, Wang Y, Heinzerling L. PMID: 42965706 [PubMed - indexed for MEDLINE]
	Dual-vector nanoengineered mRNA-CRISPR delivery systems for precision gene therapy in choroidal melanoma. Nanomedicine (Lond) Thakur SK, Malviya R, Chandra P, Sridhar SB, Shareef J, Wadhwa T. PMID: 42965688 [PubMed - indexed for MEDLINE]
	PROTAC technology for sensitizing melanoma to immune checkpoint therapy. J Exp Clin Cancer Res Zhou Q, Zhang X, Zhao C, Chen D, Chu C, Jin X. PMID: 42958414 [PubMed - indexed for MEDLINE]
	Melanoma diagnosis by artificial intelligence in general practice: from artifacts in imaging to equitable implementation and clinical generalizability. Melanoma Res Kanagaraj Muthu-Pandian C. PMID: 42956178 [PubMed - in process]

Articles 1 - 20 / 46556

Page 1 of 2328



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy